Novogen (NASDAQ:KZIA) Price Target Raised to $40.00

Novogen (NASDAQ:KZIA) had its price target boosted by BTIG Research from $34.00 to $40.00 in a report published on Tuesday,Benzinga reports. They currently have a buy rating on the stock.

A number of other research firms also recently weighed in on KZIA. Lake Street Capital began coverage on Novogen in a research report on Thursday, June 11th. They issued a “buy” rating and a $32.00 target price for the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Novogen in a research report on Friday, July 17th. Finally, Canaccord Genuity Group started coverage on Novogen in a research note on Thursday, August 13th. They issued a “buy” rating and a $29.00 price objective on the stock. Six analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Novogen has a consensus rating of “Moderate Buy” and an average price target of $27.33.

Novogen Trading Down 3.6%

Novogen stock opened at $12.16 on Tuesday. Novogen has a 12-month low of $4.86 and a 12-month high of $17.40. The firm has a 50 day simple moving average of $13.35 and a 200-day simple moving average of $11.47.

About Novogen

Novogen (NASDAQ:KZIA) is a clinical-stage biotechnology company focused on the discovery and development of novel small-molecule therapeutics for the treatment of cancer. The company’s pipeline includes GDC-0084, a brain-penetrant phosphoinositide 3-kinase (PI3K) inhibitor in Phase II development for glioblastoma, as well as Cantrixil, an orally bioavailable small molecule designed to target treatment-resistant ovarian cancer stem cells. Novogen’s research efforts leverage structure-based drug design to optimize selectivity and pharmacokinetic profiles, seeking to address high-unmet medical needs in oncology.

Founded in Australia and now headquartered in New York City, Novogen maintains research facilities in Perth and collaborates with academic institutions and contract research organizations worldwide.